• Bluejay Diagnostics will implement a 1-for-4 reverse stock split effective at 12:01 a.m. Eastern Time on November 3, 2026.
• Shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market that day under the existing symbol BJDX.
• Outstanding common shares will decline from approximately 4,468,051 to approximately 1,117,013.
• Cash payments will replace fractional shares; outstanding equity awards and warrants will be adjusted accordingly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bluejay Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-115717), on November 04, 2026, and is solely responsible for the information contained therein.